Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer Treatment
Recruiting now
Conditions studied: Breast Neoplasms
In brief
After 1 year, more than 50% experience upper limb (UL) complaints after treatment for breast cancer. These complaints are disabling and cause limitations in daily life and this leads to a decrease in the patient's quality of life. The cause of these UL complaints is complex and multifactorial. Due to breast cancer treatment, the structural (tissue composition and volume) and mechanical (tissue stiffness) properties of the soft tissue may change. These changes can occur in the muscle, skin and surrounding fascia and especially in the soft tissue around the breast and axilla where that treatment is localised. Ultrasound with specific 'add-on' techniques can objectively assess these features and provide a picture of their role in UL function after breast cancer. The first aim in this study is to investigate the reliability and validity of conventional 2D ultrasound for 1) soft tissue composition and 2) soft tissue thickness at the level of the breast and upper limb. The reliability and validity of shear wave elastography, a specific complement to conventional 2D ultrasound, to assess tissue stiffness will also be examined.
Key facts
- Study ID
- NCT06180642
- Run by
- Universiteit Antwerpen
- People needed
- 90
- Starts
- 2023-05-02
- Expected to finish
- 2026-05-02
- Last updated by the study team
- 2024-12-11
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Healthy women (QuickDASH <15) age-matched with a breast cancer patient from the main study
- Comprehensive of the Dutch language
- Exclusion criteria:
- upper limb dysfunctions
- Diagnosis of neurological or rheumatological condition, diabetes
You may not qualify if…
- Bilateral surgery, widespread distance metastases, previous breast surgery
- Diagnosis of neurological or rheumatological condition
- upper limb dysfunctions caused by other reasons
- Breast cancer patients with upper limb dysfunctions (n=30) Inclusion Criteria
- Patients with unilateral primary breast cancer
- Surgery including, either: Mastectomy with axillary lymph node dissection or sentinel lymph node biopsy or breast conserving surgery with axillary lymph node dissection or sentinel lymph node biopsy
- At least 3 months after surgery or radiotherapy in order to take into account wound healing
- Comprehensive of the Dutch language
- QuickDASH score >15/100
- Exclusion Criteria:
- Bilateral surgery, widespread distance metastases, previous breast surgery
- Diagnosis of neurological or rheumatological condition
- upper limb dysfunctions caused by other reasons
- Healthy volunteers (n=30)
- Inclusion criteria:
- Healthy women (QuickDASH <15) age-matched with a breast cancer patient from the main study
- Comprehensive of the Dutch language
- Exclusion criteria:
- upper limb dysfunctions
- Diagnosis of neurological or rheumatological condition, diabetes
Where it is running
- Universiteit Antwerpen — Antwerp, Belgium (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.